Tweet
Daily Mail
<img alt="" height="1" width="1" />
Experimental Drug Benefits Patients with Advanced Prostate Cancer
NCI Cancer Bulletin
The experimental drug cabazitaxel has improved the survival of some patients with advanced prostate cancer compared with those who received standard chemotherapy, according to results from a randomized phase III clinical trial presented last week at ...
Doctor's Specialty Often Steers Prostate Cancer CareBusinessWeek
'Tame' virus may help fight cancerThe Press Association
Dietary Fat and Prostate Cancer RiskRenal and Urology News
HemOncToday -AHN | All Headline News -dBTechno
all 68 news articles »
More...